Structures by: Wang J. T.
Total: 103
C22H34NO6Si
C22H34NO6Si
MedChemComm (2013) 4, 5 783
a=23.812(7)Å b=6.6660(7)Å c=18.297(4)Å
α=90.00° β=123.79(3)° γ=90.00°
C21H24Co2Cu3Mo10N9O46,H2O
C21H24Co2Cu3Mo10N9O46,H2O
Dalton transactions (Cambridge, England : 2003) (2019) 48, 6 2160-2169
a=12.4355(5)Å b=15.6728(8)Å c=17.6863(9)Å
α=76.352(4)° β=71.082(4)° γ=89.701(4)°
C16H26Cu2N6O6,Co2Mo10O38
C16H26Cu2N6O6,Co2Mo10O38
Dalton transactions (Cambridge, England : 2003) (2019) 48, 6 2160-2169
a=23.3279(8)Å b=12.4706(5)Å c=22.1391(12)Å
α=90° β=96.520(4)° γ=90°
C23H23OPSe2
C23H23OPSe2
Journal of the Chemical Society, Perkin Transactions 1 (2001) 9 1140
a=13.524(3)Å b=22.784(5)Å c=14.838(3)Å
α=90.00° β=112.98(3)° γ=90.00°
C22H30Cl2O8P2PdSe2
C22H30Cl2O8P2PdSe2
Journal of the Chemical Society, Perkin Transactions 1 (2001) 9 1140
a=7.655(2)Å b=15.047(3)Å c=20.023(4)Å
α=72.73(3)° β=83.49(3)° γ=80.64(3)°
C26H29OPSe2
C26H29OPSe2
Journal of the Chemical Society, Perkin Transactions 1 (2001) 9 1140
a=8.294(2)Å b=8.305(2)Å c=18.438(4)Å
α=100.38(3)° β=96.14(3)° γ=102.78(3)°
<i>rac</i>-(Acetonitrile-κ<i>N</i>)(3-aminopyridine-κ<i>N</i>)[2,2-bis(diphenylphosphanyl)-1,1'-binaphthyl-κ^2^<i>P</i>,<i>P</i>']copper(I) hexafluoridophosphate dichloromethane monosolvate
C51H41CuN3P2,PF6,CH2Cl2
Acta Crystallographica Section C (2020) 76, 2
a=20.089(3)Å b=11.1502(17)Å c=21.972(3)Å
α=90° β=97.945(5)° γ=90°
Methyl 3-dimethylamino-2-{2-[2-(dimethylamino)-1-(3-phenyl-1,2,4-oxadiazol-5- yl)vinyloxy]phenyl}acrylate
C24H26N4O4
Acta Crystallographica Section E (2004) 60, 10 o1709-o1711
a=11.220(2)Å b=12.260(3)Å c=17.762(4)Å
α=71.06(3)° β=86.35(3)° γ=85.19(3)°
1-(2-hydroxyphenyl)octan-1-one
C14H20O2
Acta Crystallographica Section E (2006) 62, 5 o1793-o1794
a=6.8560(14)Å b=8.4850(17)Å c=11.547(2)Å
α=95.20(3)° β=102.54(3)° γ=93.15(3)°
5-(4-Methoxyphenyl)-1-phenylpyrazolidin-3-one
C16H16N2O2
Acta Crystallographica Section E (2005) 61, 7 o2246-o2247
a=13.151(3)Å b=7.1660(14)Å c=14.700(3)Å
α=90.00° β=97.53(3)° γ=90.00°
Methyl 3-(dimethylamino)-2-(2-{1-[3-(2-methylphenyl)-1,2,4-oxadiazol -5-yl]-2-(dimethylamino)vinyloxyl}phenyl)acrylate
C25H28N4O4
Acta Crystallographica Section E (2005) 61, 5 o1426-o1428
a=10.250(2)Å b=10.691(2)Å c=12.263(3)Å
α=105.46(3)° β=110.74(3)° γ=92.30(3)°
3-[5-(3,5-Dimethylphenyl)-1,3,4-thiadiazol-2-yl]-2-(4- methoxyphenyl)thiazolidin-4-one
C20H19N3O2S2
Acta Crystallographica Section E (2006) 62, 6 o2115-o2116
a=13.892(3)Å b=7.2560(15)Å c=18.912(4)Å
α=90.00° β=95.86(3)° γ=90.00°
4-{[3-(2-Chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl}-1-[(2,6- dimethylphenyl)aminocarbonylmethyl]piperazine
C23H26ClN5O2
Acta Crystallographica Section E (2005) 61, 7 o1994-o1996
a=12.2960(10)Å b=10.587(2)Å c=17.164(2)Å
α=90.00° β=99.77(3)° γ=90.00°
2,5-dibenzoyl-1,4-phenylenediamine
C20H16N2O2
Acta Crystallographica Section E (2005) 61, 7 o2209-o2210
a=7.4651(15)Å b=13.0034(16)Å c=15.9759(18)Å
α=90° β=90° γ=90°
3-[5-(2,4-Dichlorophenyl)-1,3,4-thiadiazol-2-yl]-2-phenylthiazolidin-4-one
C17H11Cl2N3OS2
Acta Crystallographica Section E (2006) 62, 5 o1930-o1931
a=7.9700(16)Å b=6.1550(12)Å c=34.738(7)Å
α=90.00° β=90.20(3)° γ=90.00°
1-[(2,6-Dimethylphenyl)aminocarbonylmethyl]- 4-{[3-(4-nitrophenyl)-1,2,4-oxadiazol-5-yl]methyl}piperazine
C23H26N6O4
Acta Crystallographica Section E (2004) 60, 11 o2041-o2042
a=7.2240(14)Å b=9.5650(19)Å c=33.245(7)Å
α=90.00° β=95.22(3)° γ=90.00°
3,3-Dibenzylbenzo[b]furan-2(3H)-one
C22H18O2
Acta Crystallographica Section E (2004) 60, 10 o1842-o1843
a=12.650(3)Å b=15.488(3)Å c=8.772(2)Å
α=90.00° β=90.00° γ=90.00°
Methyl {2-[(3-phenyl-1,2,4-oxadiazol-5-yl)methoxy]phenyl}acetate
C18H16N2O4
Acta Crystallographica Section E (2004) 60, 9 o1478-o1480
a=8.7850(18)Å b=9.848(2)Å c=10.345(2)Å
α=77.90(3)° β=79.12(3)° γ=67.39(3)°
Methyl 2-{[3-(2-methyl)phenyl-1,2,4-oxadiazol-5-yl]methoxy}phenylacetate
C19H18N2O4
Acta Crystallographica Section E (2005) 61, 5 o1390-o1392
a=11.444(2)Å b=7.9540(16)Å c=19.356(4)Å
α=90.00° β=102.83(3)° γ=90.00°
3-[3-(Methoxyl)phenyl]-5-chloromethyl-1,2,4-oxadiazole
C10H9ClN2O2
Acta Crystallographica Section E (2005) 61, 5 o1446-o1447
a=7.2350(14)Å b=9.5600(19)Å c=15.454(3)Å
α=90.00° β=97.03(3)° γ=90.00°
Methyl 2-[3-(2-chlorophenyl)-1,2,4-oxadiazol-5-ylmethoxy]phenylacetate
C18H15ClN2O4
Acta Crystallographica Section E (2005) 61, 6 o1858-o1860
a=11.314(2)Å b=7.9510(16)Å c=19.598(4)Å
α=90.00° β=103.08(3)° γ=90.00°
Methyl 2-(2-{1-[3-(2-chlorophenyl)-1,2,4-oxadiazol-5-yl]-2- (dimethylamino)vinyloxy}phenyl)-3-(dimethylamino)acrylate
C24H25ClN4O4
Acta Crystallographica Section E (2005) 61, 11 o3879-o3880
a=16.088(3)Å b=8.3060(17)Å c=17.358(4)Å
α=90.00° β=95.79(3)° γ=90.00°
1-[(2,6-Dimethylphenyl)aminocarbonylmethyl]4-{[3-(3-methoxyphenyl)- 1,2,4-oxadiazol-5-yl]methyl}piperazine
C24H29N5O3
Acta Crystallographica Section E (2005) 61, 11 o3750-o3751
a=17.120(3)Å b=10.271(2)Å c=13.042(3)Å
α=90.00° β=91.10(3)° γ=90.00°
Bis(triaquasodium) 2,5-dibenzoylterephthalate tetrahydrate
2H6Na1O3,C22H12O62,4H2O
Acta Crystallographica Section E (2005) 61, 12 m2610-m2612
a=6.2800(13)Å b=8.6650(17)Å c=13.709(3)Å
α=105.41(3)° β=99.37(3)° γ=92.70(3)°
N-n-butylpyridinium bromide
C9H14N,Br
Acta Crystallographica Section E (2006) 62, 2 o516-o517
a=8.3040(17)Å b=10.783(2)Å c=11.699(2)Å
α=90.00° β=90.00° γ=90.00°
Poly[[tetra-μ~2~-aqua-diaqua-μ~2~-2,5-dibenzoylterephthalato dipotassium(I)] dihydrate]
C24H22O12,2H2O
Acta Crystallographica Section E (2006) 62, 2 m201-m203
a=6.153(2)Å b=8.455(3)Å c=13.769(4)Å
α=69.441(11)° β=79.673(13)° γ=87.265(14)°
1,2-Dihydroenzocyclobutene-4-carboxylic acid
C9H8O2
Acta Crystallographica Section E (2006) 62, 7 o2646-o2647
a=7.233(2)Å b=5.886(3)Å c=17.682(4)Å
α=90.00° β=98.26(2)° γ=90.00°
(Z)-2-[4-(2-Chlorophenyl)-1,3-dithiolan-2-ylidene]-2-(imidazol-1- yl)acetonitrile
C14H10ClN3S2
Acta Crystallographica Section E (2006) 62, 8 o3159-o3160
a=5.7930(12)Å b=23.652(5)Å c=10.466(2)Å
α=90.00° β=91.66(3)° γ=90.00°
N-Acryloyl glycine
C5H7NO3
Acta Crystallographica Section E (2006) 62, 8 o3344-o3345
a=18.212(4)Å b=18.318(4)Å c=7.5330(15)Å
α=90.00° β=90.00° γ=90.00°
2,5-dibenzoyl-terephthalic acid
C22H14O6,2C2H6O
Acta Crystallographica Section E (2005) 61, 7 o2237-o2238
a=6.1010(10)Å b=8.598(2)Å c=11.479(2)Å
α=94.88(3)° β=98.56(3)° γ=92.42(3)°
5-(4-Chlorophenyl)-1-phenylpyrazolidin-3-one
C15H13ClN2O
Acta Crystallographica Section E (2006) 62, 1 o233-o235
a=11.826(2)Å b=10.227(2)Å c=12.867(3)Å
α=90.00° β=115.74(3)° γ=90.00°
Methyl 2-{[3-(4-methylsulfanyl)phenyl-1,2,4-oxadiazol- 5-yl]methoxy}phenylacetate
C19H18N2O4S
Acta Crystallographica Section E (2004) 60, 11 o2122-o2124
a=8.3580(17)Å b=10.522(2)Å c=10.581(2)Å
α=90.13(3)° β=102.08(3)° γ=99.73(3)°
Methyl 2-(2-{1-[3-(3,5-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-2- (dimethylamino)vinyloxy}phenyl)-3-(dimethylamino)acrylate
C26H30N4O6
Acta Crystallographica Section E (2004) 60, 11 o2070-o2072
a=8.6500(17)Å b=10.700(2)Å c=14.817(3)Å
α=107.66(3)° β=97.50(3)° γ=95.15(3)°
Methyl 2-{[3-(4-nitrophenyl)-1,2,4-oxadiazol-5-yl]methoxy}phenylacetate
C18H15N3O6
Acta Crystallographica Section E (2004) 60, 11 o2073-o2075
a=10.436(2)Å b=5.1800(10)Å c=31.560(6)Å
α=90.00° β=92.94(3)° γ=90.00°
2-(3-Phenyl-1,2,4-oxadiazol-5-yl)-4H-1-benzopyran-3-ol
C17H12N2O3
Acta Crystallographica Section E (2004) 60, 11 o1917-o1918
a=5.6750(10)Å b=9.346(2)Å c=25.440(5)Å
α=90.00° β=92.06(3)° γ=90.00°
5-(3,4-dimethoxyphenyl)-1-phenylpyrazolidin-3-one
C17H18N2O3
Acta Crystallographica Section E (2004) 60, 3 o411-o413
a=9.011(2)Å b=9.403(2)Å c=11.621(2)Å
α=66.49(3)° β=67.67(3)° γ=62.05(3)°
5-(8-hydroxyquinolyl)guanidine dihydrochloride
C10H12N4O2,2Cl
Acta Crystallographica Section E (2004) 60, 3 o442-o443
a=10.715(2)Å b=11.333(2)Å c=22.720(5)Å
α=90.00° β=103.30(3)° γ=90.00°
Methyl 3-(dimethylamino)-2-[2-(1-{3-[4-(methylsulfanyl)phenyl]-1,2,4-oxadiazol-5-yl}- 2-(dimethylamino)vinyloxy)phenyl]acrylate
C25H28N4O4S
Acta Crystallographica Section E (2005) 61, 1 o58-o59
a=8.2940(17)Å b=12.654(3)Å c=23.601(5)Å
α=90.00° β=97.02(3)° γ=90.00°
Methyl 3-dimethylamino-2-(2-{2-dimethylamino-1-[3-(3-pyridyl)-1,2,4-oxadiazol- 5-yl]vinyloxy}phenyl)acrylate
C23H25N5O4
Acta Crystallographica Section E (2005) 61, 4 o1010-o1012
a=8.6250(17)Å b=9.6390(19)Å c=26.273(5)Å
α=90.00° β=91.28(3)° γ=90.00°
5-Chloromethyl-3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazole
C10H9ClN2O3S
Acta Crystallographica Section E (2005) 61, 4 o953-o954
a=5.6170(11)Å b=12.247(2)Å c=16.993(3)Å
α=90.00° β=93.06(3)° γ=90.00°
3-[5-(4-Fluorophenyl)-1,3,4-thiadiazol-2-yl]-2-phenylthiazolidin-4-one
C17H12FN3OS2
Acta Crystallographica Section E (2006) 62, 2 o746-o747
a=6.4630(13)Å b=10.911(2)Å c=11.371(2)Å
α=97.91(3)° β=94.37(3)° γ=99.12(3)°
Potassium 2-benzoylbenzoate dihydrate
K,C14H9O3,2H2O1
Acta Crystallographica, Section E (2006) 62, 2 o427-o428
a=10.391(4)Å b=7.771(3)Å c=33.314(13)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Fluorophenyl)-3-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]thiazolidin- 4-one
C18H14FN3O2S2
Acta Crystallographica Section E (2006) 62, 9 o3984-o3985
a=17.750(4)Å b=6.3720(13)Å c=31.761(6)Å
α=90.00° β=101.55(3)° γ=90.00°
N-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-3,5-dimethylbenzamide
C18H17N3O2S
Acta Crystallographica Section E (2006) 62, 10 o4412-o4413
a=7.7105(14)Å b=8.3328(18)Å c=14.454(2)Å
α=74.44(3)° β=83.07(3)° γ=69.18(3)°
(E)-[4-(2-Chlorophenyl)-1,3-dithiolan-2-ylidene]-1-imidazolyl-acetonitrile
C14H10ClN3S2
Acta Crystallographica Section E (2006) 62, 11 o5052-o5053
a=5.5690(11)Å b=9.5120(19)Å c=13.372(3)Å
α=90.00° β=95.05(3)° γ=90.00°
N-(methylacryloyl)glycine
C6H9NO3
Acta Crystallographica Section E (2007) 63, 2 o485-o486
a=8.6340(17)Å b=10.343(2)Å c=9.1600(18)Å
α=90.00° β=115.04(3)° γ=90.00°
(R)-Diethyl [(4-chlorophenyl)(5-m-tolyl-1,3,4-thiadiazol-2-ylamino)methyl]phosphonate
C20H23ClN3O3PS
Acta Crystallographica Section E (2007) 63, 2 o934-o935
a=9.772(2)Å b=11.104(2)Å c=12.588(3)Å
α=100.14(3)° β=109.80(3)° γ=111.17(3)°
N-acryloyltryptophane
C15H16N2O3
Acta Crystallographica Section E (2007) 63, 6 o2846-o2847
a=9.4220(19)Å b=10.587(2)Å c=14.328(3)Å
α=90.00° β=90.00° γ=90.00°
4,4'-bibenzocyclobutene
C16H14
Acta Crystallographica Section E (2007) 63, 6 o2808-o2808
a=8.0250(16)Å b=11.365(2)Å c=12.850(3)Å
α=90.00° β=101.19(3)° γ=90.00°
2,10,12-Trimethyl-12H-5,7-dioxa-6-thiadibenzo[a,d]cyclooctene 6-oxide
C16H16O3S
Acta Crystallographica Section E (2007) 63, 6 o2992
a=14.122(3)Å b=8.0880(16)Å c=25.343(5)Å
α=90.00° β=90.00° γ=90.00°
Methyl 3-carboxy-7-(tert-butoxycarbonyl)-4,7-diazaheptanoate
C12H22N2O6
Acta Crystallographica Section E (2007) 63, 7 o3079-o3079
a=10.824(2)Å b=15.204(3)Å c=8.9300(18)Å
α=90° β=90° γ=90°
2,2'-Bis[4-(benzyloxy)phenyl]propane
C29H28O2
Acta Crystallographica Section E (2007) 63, 9 o3726-o3726
a=18.808(4)Å b=6.3900(13)Å c=18.925(4)Å
α=90.00° β=90.97(3)° γ=90.00°
(S)-Diethyl {(4-fluorophenyl)[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2- ylamino]methyl}phosphonate
C20H23FN3O4PS
Acta Crystallographica Section E (2007) 63, 10 o4158-o4158
a=9.4140(19)Å b=10.227(2)Å c=12.923(3)Å
α=110.44(3)° β=98.80(3)° γ=100.58(3)°
N-acryloylglycylglycine monohydrate
C7H10N2O4,H2O
Acta Crystallographica Section E (2007) 63, 12 o4580-o4580
a=13.332(3)Å b=5.1490(10)Å c=14.458(3)Å
α=90.00° β=103.09(3)° γ=90.00°
(R,S)-Diethyl {[5-(2,4-dichlorophenyl)-1,3,4-thiadiazol-2-ylamino](phenyl)methyl}phosphonate
C19H20Cl2N3O3PS
Acta Crystallographica Section E (2007) 63, 12 o4648-o4648
a=8.4870(17)Å b=16.530(3)Å c=15.703(3)Å
α=90.00° β=94.47(3)° γ=90.00°
6-Methyl-3-p-tolyl-3,4-dihydroquinazoline
C16H16N2
Acta Crystallographica Section E (2007) 63, 12 o4734-o4734
a=6.2745(7)Å b=14.6008(15)Å c=14.0154(11)Å
α=90.00° β=94.39(3)° γ=90.00°
4-Bromo-2,6-dimethylanilinium bromide monohydrate
C8H11BrN,Br,H2O
Acta Crystallographica Section E (2008) 64, 1 o244-o244
a=7.1630(14)Å b=18.649(4)Å c=8.4770(17)Å
α=90.00° β=109.98(3)° γ=90.00°
Dibromidobis(pyrazine-2-carboxylic acid-κN^4^)mercury(II) dihydrate
C10H8Br2HgN4O4,2(H2O)
Acta Crystallographica Section E (2008) 64, 1 m13-m13
a=13.8950(10)Å b=5.7176(2)Å c=21.8753(7)Å
α=90.00° β=102.544(2)° γ=90.00°
1,4-Bis(benzyloxy)-2-tert-butylbenzene
C24H26O2
Acta Crystallographica Section E (2008) 64, 3 o620
a=6.5570(13)Å b=23.772(5)Å c=12.924(3)Å
α=90.00° β=93.21(3)° γ=90.00°
<i>N</i>-(4,5-diazafluoren-9-ylidene)aniline
C17H11N3
Acta Crystallographica Section E (2008) 64, 7 o1221
a=7.1950(14)Å b=8.5860(17)Å c=11.876(2)Å
α=80.63(3)° β=74.78(3)° γ=66.46(3)°
12-Nitromethyl-14-deoxyandrographolide
C21H31NO6
Acta Crystallographica Section E (2008) 64, 7 o1343
a=11.503(2)Å b=13.151(3)Å c=13.434(3)Å
α=90.00° β=90.00° γ=90.00°
2-(2,4-Dichlorophenyl)-3-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-1,3- thiazolidin-4-one
C18H13Cl2N3O2S2
Acta Crystallographica Section E (2008) 64, 5 o795
a=7.1310(14)Å b=8.1540(16)Å c=16.671(3)Å
α=93.19(3)° β=96.43(3)° γ=105.89(3)°
Dichloridobis(5-<i>m</i>-tolyl-1,3,4-thiadiazol-2-ylamine-κN^3^)zinc(II)
C18H18Cl2N6S2Zn
Acta Crystallographica Section E (2008) 64, 5 m692-m693
a=10.826(2)Å b=11.233(2)Å c=17.892(4)Å
α=90.00° β=90.10(3)° γ=90.00°
5-m-Tolyl-1,3,4-thiadiazol-2-ylamine
C9H9N3S
Acta Crystallographica Section E (2007) 63, 2 o717-o718
a=10.793(2)Å b=10.820(2)Å c=17.607(4)Å
α=73.85(3)° β=78.97(3)° γ=73.51(3)°
1-(2',4'-Difluorophenyl)-2-(1H-imidazol-1-yl)ethanone
C11H8F2N2O
Acta Crystallographica Section E (2007) 63, 4 o1640-o1641
a=8.0770(16)Å b=10.045(2)Å c=12.238(2)Å
α=90.00° β=90.00° γ=90.00°
3-[5-(4-Fluorophenyl)-1,3,4-thiadiazol-2-yl]-2-(4-methoxyphenyl)- 1,3-thiazolidin-4-one
C18H14FN3O2S2
Acta Crystallographica Section E (2008) 64, 7 o1359
a=6.4550(13)Å b=8.9200(18)Å c=16.483(3)Å
α=75.78(3)° β=82.44(3)° γ=71.11(3)°
2-Methoxy-<i>N</i>-[5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl]benzamide hemihydrate
C17H15N3O3S,0.5(H2O)
Acta Crystallographica Section E (2008) 64, 8 o1637
a=29.950(6)Å b=14.561(3)Å c=7.6520(15)Å
α=90.00° β=94.78(3)° γ=90.00°
N-acryloylphenylalanie
C12H13NO3
Acta Crystallographica Section E (2008) 64, 8 o1483
a=6.0050(12)Å b=7.5820(15)Å c=12.512(3)Å
α=90.00° β=98.58(3)° γ=90.00°
3-{5-[3-(Trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-yl}- 2-phenylthiazolidin-4-one
C18H12F3N3OS2
Acta Crystallographica Section E (2006) 62, 9 o4072-o4074
a=7.5370(15)Å b=10.538(2)Å c=11.380(2)Å
α=79.86(3)° β=78.03(3)° γ=84.70(3)°
1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone
C10H7F2N3O
Acta Crystallographica Section E (2007) 63, 3 o1330-o1331
a=4.7000(9)Å b=9.853(2)Å c=10.898(2)Å
α=79.04(3)° β=81.81(3)° γ=88.15(3)°
Rac-Diethyl {[5-(4-fluorophenyl)-1,3,4-thiadiazol-2-ylamino](phenyl)methyl}phosphonate
C19H21FN3O3PS
Acta Crystallographica Section E (2007) 63, 3 o1304-o1305
a=9.874(2)Å b=15.415(3)Å c=14.412(3)Å
α=90.00° β=104.17(3)° γ=90.00°
Bis(2-hydroxy-5-methylphenyl)ethane
C16H18O2
Acta Crystallographica Section E (2007) 63, 5 o2357-o2358
a=8.6680(17)Å b=9.6400(19)Å c=16.424(3)Å
α=90.00° β=90.00° γ=90.00°
N-benzylidene-5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-amine
C16H13N3OS
Acta Crystallographica Section E (2007) 63, 5 o2363-o2364
a=7.4253(7)Å b=11.5124(11)Å c=33.0405(19)Å
α=90.00° β=93.10(3)° γ=90.00°
2-(2,4-Dichlorophenyl)-3-[5-(3,5-dimethylphenyl)-1,3,4-thiadiazol-2- yl]thiazolidin-4-one
C19H15Cl2N3OS2
Acta Crystallographica Section E (2008) 64, 1 o260-o260
a=8.1760(16)Å b=9.1650(18)Å c=14.483(3)Å
α=80.60(3)° β=80.82(3)° γ=63.92(3)°
2-[1-Chloro-3-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-yloxycarbonyl]benzoic acid
C15H14ClN3O6
Acta Crystallographica Section E (2008) 64, 2 o472-o472
a=15.214(3)Å b=16.271(3)Å c=15.069(3)Å
α=90.00° β=113.86(3)° γ=90.00°
6,10,16,19-Tetraoxatrispiro[4.2.2.4.2.2]nonadecane
C15H24O4
Acta Crystallographica Section E (2008) 64, 2 o498-o498
a=25.605(5)Å b=5.5820(11)Å c=10.337(2)Å
α=90° β=90.22(3)° γ=90°
5-(2-Bromophenyl)-1,3,4-thiadiazol-2-amine
C8H6BrN3S
Acta Crystallographica Section E (2008) 64, 10 o1884
a=14.869(3)Å b=8.0250(16)Å c=7.9480(16)Å
α=90.00° β=97.43(3)° γ=90.00°
(R)-3-Hydroxy-N,N-dimethyl-3-(2-thienyl)propanamine
C9H15NOS
Acta Crystallographica Section E (2006) 62, 11 o5202-o5203
a=6.1000(12)Å b=9.6340(19)Å c=17.302(4)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Chlorophenyl)-3-[5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl]thiazolidin- 4-one
C18H14ClN3O2S2
Acta Crystallographica Section E (2006) 62, 11 o5274-o5275
a=6.4380(13)Å b=31.803(6)Å c=9.2650(19)Å
α=90.00° β=109.08(3)° γ=90.00°
5-(4-Fluorophenyl)-1,3,4-thiadiazol-2-ylamine
C8H6FN3S
Acta Crystallographica Section E (2006) 62, 12 o5547-o5548
a=8.8020(18)Å b=8.9610(18)Å c=11.035(2)Å
α=90.00° β=97.19(3)° γ=90.00°
N-acryloyl-L-alanine
C6H9NO3
Acta Crystallographica Section E (2007) 63, 1 o191-o192
a=8.3670(17)Å b=8.7730(18)Å c=10.350(2)Å
α=90.00° β=90.00° γ=90.00°
N-acryoylaspartic acid
C7H9NO5
Acta Crystallographica Section E (2007) 63, 1 o207-o209
a=8.1560(16)Å b=10.079(2)Å c=11.084(2)Å
α=90.16(3)° β=94.17(3)° γ=104.99(3)°
3,5-Dimethyl-N-[5-(3-tolyl)-1,3,4-thiadiazol-2-yl]benzamide
C18H17N3OS
Acta Crystallographica Section E (2007) 63, 2 o885-o886
a=8.6420(17)Å b=9.0980(18)Å c=10.924(2)Å
α=84.08(3)° β=72.59(3)° γ=79.42(3)°
<i>N</i>,<i>N</i>-Dimethyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine
C19H21NOS
Acta Crystallographica Section E (2008) 64, 3 o553
a=9.6140(19)Å b=18.578(4)Å c=9.905(2)Å
α=90.00° β=104.53(3)° γ=90.00°
1-Benzyl-1,4-diazepan-5-one
C12H16N2O
Acta Crystallographica Section E (2008) 64, 3 o569
a=12.602(3)Å b=7.4920(15)Å c=12.824(3)Å
α=90.00° β=111.00(3)° γ=90.00°
<i>N</i>-{(<i>E</i>)-4-[(<i>E</i>)-(Dodecylimino)methyl]benzylidene}dodecan-\ 1-imine ?
C32H56N2
Acta Crystallographica Section E (2008) 64, 3 o565
a=4.7370(9)Å b=5.5190(11)Å c=30.315(6)Å
α=91.18(3)° β=93.44(3)° γ=101.75(3)°
Dimethyl 2,2-bis(2-cyanoethyl)malonate
C11H14N2O4
Acta Crystallographica Section E (2008) 64, 5 o856
a=13.071(3)Å b=8.5060(17)Å c=10.914(2)Å
α=90.00° β=90.55(3)° γ=90.00°
Diethyl {(4-methoxyphenyl)[5-(4-nitrophenyl)-1,3,4-thiadiazol-2- ylamino]methyl}phosphonate
C20H23N4O6PS
Acta Crystallographica Section E (2008) 64, 8 o1376
a=11.481(2)Å b=19.426(4)Å c=11.960(2)Å
α=90.00° β=117.08(3)° γ=90.00°
Aquadinitrato(quioxalino[2,3-<i>f</i>][1,10]phenanthroline)nickel(II) monohydrate
C18H12N6NiO7,H2O
Acta Crystallographica Section E (2009) 65, 4 m475
a=7.300(3)Å b=27.872(12)Å c=9.950(4)Å
α=90.00° β=109.005(6)° γ=90.00°
1-(4,5-Dinitro-10-azatricyclo[6.3.1.0^2,7^]dodeca-2,4,6-trien-10-yl)-2,2,2-trifluoroethanone
C13H10F3N3O5
Acta Crystallographica Section E (2008) 64, 12 o2425
a=9.6400(19)Å b=7.7430(15)Å c=18.687(4)Å
α=90.00° β=96.98(3)° γ=90.00°
Biphenyl-2,2'-diyl diacetate
C16H14O4
Acta Crystallographica Section E (2008) 64, 12 o2248
a=8.8380(18)Å b=18.204(4)Å c=8.9620(18)Å
α=90.00° β=108.75(3)° γ=90.00°
1,1'-(Hexane-1,6-diyl)dipyridinium bis(hexafluorophosphate)
C16H22N22,2(F6P)
Acta Crystallographica Section E (2008) 64, 12 o2495
a=7.9140(16)Å b=9.2930(18)Å c=9.4870(19)Å
α=65.13(3)° β=65.46(3)° γ=74.37(3)°
<i>N</i>-(4,5-Diazafluoren-9-ylidene)-4-methylaniline
C18H13N3
Acta Crystallographica Section E (2009) 65, 1 o6
a=7.5970(15)Å b=8.6100(17)Å c=10.998(2)Å
α=77.11(3)° β=87.48(3)° γ=85.79(3)°
1,2-Bis(1,3-benzothiazol-2-yl)benzene
C20H12N2S2
Acta Crystallographica Section E (2009) 65, 1 o158
a=10.748(2)Å b=19.148(4)Å c=8.1840(16)Å
α=90.00° β=100.77(3)° γ=90.00°
3,3'-Dimethyl-1,1'-(propane-1,3-diyl)diimidazol-1-ium bis(hexafluorophosphate)
C11H18N42,2(PF6)
Acta Crystallographica Section E (2008) 64, 12 o2480
a=8.2300(16)Å b=10.192(2)Å c=12.856(3)Å
α=107.99(3)° β=104.50(3)° γ=96.35(3)°
3,3-Bis(2-cyanoethyl)-2,4-pentanedione
C11H14N2O2
Acta Crystallographica Section E (2009) 65, 1 o15
a=12.562(3)Å b=7.8700(16)Å c=10.941(2)Å
α=90.00° β=84.91(3)° γ=90.00°
2,2'-Hexamethylenedi-1,3-benzothiazole
C20H20N2S2
Acta Crystallographica Section E (2009) 65, 2 o293
a=5.7590(12)Å b=8.3030(17)Å c=18.974(4)Å
α=90.00° β=96.03(3)° γ=90.00°
2-nitro-<i>N</i>-propylbenzamide
C10H12N2O3
Acta Crystallographica Section E (2009) 65, 7 o1488
a=15.835(3)Å b=9.3910(19)Å c=23.618(5)Å
α=90.00° β=108.35(3)° γ=90.00°
4,5-Diaza-9<i>H</i>-fluoren-9-imine
C11H7N3
Acta Crystallographica Section E (2010) 66, 7 o1802
a=10.008(2)Å b=12.407(3)Å c=6.8140(14)Å
α=90.00° β=99.74(3)° γ=90.00°
<i>N</i>-(4,5-Diaza-9<i>H</i>-fluoren-9-ylidene)-4-methoxyaniline
C18H13N3O
Acta Crystallographica Section E (2010) 66, 7 o1804
a=8.3070(17)Å b=12.839(3)Å c=13.233(3)Å
α=90.00° β=97.12(3)° γ=90.00°